Pediatric Oncology Prof. Dr. Nur Olgun
✓ Medically verified profileProf. Dr. Nur Olgun
✓ Medically verified profile
Quick answer
Prof. Dr. Nur Olgun is a Pediatric Oncology specialist at Acibadem Kent Hospital in İzmir, with 41+ years of experience.
She treats childhood cancers with a particular focus on neuroblastoma, including high-risk, relapsed, and refractory neuroblastoma, and handles pediatric chemotherapy, chemo-immunotherapy, dinutuximab beta immunotherapy, targeted therapy, and genomic profiling for neuroblastoma. She consults in Turkish and English and offers online video consultations.
About Prof. Dr. Nur Olgun
Prof. Dr. Nur Olgun is a Pediatric Oncology physician with 41 years of experience. Prof. Dr. Olgun’s listed areas of expertise include high-risk neuroblastoma, relapsed neuroblastoma, refractory neuroblastoma, pediatric chemotherapy, dinutuximab beta immunotherapy, targeted therapy for neuroblastoma, and genomic profiling of neuroblastoma.
Prof. Dr. Olgun graduated from Ege University Faculty of Medicine in 1979 and completed Pediatrics at Dokuz Eylul University Faculty of Medicine in 1984. Prof. Dr. Olgun was awarded Associate Professor by Dokuz Eylul University, Institute of Oncology, in 1989, and Professor Doctor by the same institute in 1995. Prof. Dr. Olgun was a Faculty Member at Dokuz Eylül University, Faculty of Medicine, Department of Pediatrics, Division of Pediatric Oncology, from 1985 to 1992. Prof. Dr. Olgun joined Acibadem Health Group in 2025 and practises at Acibadem Kent Hospital in İzmir, Türkiye.
The profile lists 7 professional bodies, among them the International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN), the Pediatric Oncology East and Mediterranean (POEM) Group, and the International Society of Paediatric Oncology (SIOP).
The profile lists 10 publications dated between 2003 and 2025. Listed work includes neuroblastoma treatment regimens, protein expression and genetic variants in neuroblastoma, and birth weight in relation to neuroblastoma risk.
Prof. Dr. Olgun speaks Turkish and English. Online consultation is available, allowing patients abroad to speak with Prof. Dr. Olgun before travelling.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 1998Dokuz Eylul University Faculty of Medicine, Pediatric Hematology and Oncology
- 1995Dokuz Eylul University, Institute of Oncology, Professor Doctor
- 1989Dokuz Eylul University, Institute of Oncology, Associate Professor
- 1984Dokuz Eylul University Faculty of Medicine Pediatrics
- 1979Ege University Faculty of Medicine
Professional Experience
- 2025Acibadem Health Group
- 2025Dokuz Eylul University, Institute of Oncology, Pension
- 2022–2024Dokuz Eylul University, Faculty of Medicine, Dean
- 2012–2024Dokuz Eylul University, Institute of Oncology, Institute Director
- 1992–2025Dokuz Eylul University, Institute of Oncology, Faculty Member, Institute Director
- 1985–1992Dokuz Eylül University, Faculty of Medicine, Department of Pediatrics, Division of Pediatric Oncology, Faculty Member
Professional Memberships
- Turkish Medical Association
- International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN)
- The Pediatric Oncology East and Mediterranean (POEM) Group
- Turkish Pediatric Oncology Group (TPOG) Association
- Turkish Cancer Research and Fight Foundation
- International Society of Paediatric Oncology (SIOP)
- Turkish Cancer Research and Fighting Organization, Izmir Branch
Selected Publications
- Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes J Clin Med. 2025 Jan 31;14(3):934 Olgun N, Arayici ME, Kizmazoglu D, Cecen RE.
- Investigation of YAP-1, OTX-2, and nestin protein expressions in neuroblastoma: a preliminary study. Ann Clin Transl Neurol. 2024 Aug;11(8):2153-2165. Kum Özşengezer S, Altun ZS, Sanlav G, Baran B, Kızmazoğlu D, Aktaş S, Keskinoğlu P, Olgun N.
- Low Expression of CASP8 Could be a Prognostic Biomarker in Neuroblastoma Patients. J Child Neurol. 2024 Oct;39(11-12):386-394. Altun Z, Ceyhan M, Yuan H, Kizmazoglu D, Aktas S, Olgun N.
- Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma Gene. 2023 Apr 15;860:147233. Altun Z, Yuan H, Baran B, Aktaş S, Sönmez EE, Küçük C, Olgun N.
- The association between birth weight and the risk of neuroblastoma: a meta-analysis of observational studies involving 4,361,141 participants. Am J Cancer Res. 2023 Sep 15;13(9):3854-3863. Olgun HN, Arayici ME, Cecen RE, Basbinar Y, Ellidokuz H.
- Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patient Clin Med Insights Oncol. 2023 Sep 19;17:11795549231199926. Baran B, Sanlav G, Kizmazoglu D, Kum Ozsengezer S, Aktas S, Altun Z, Olgun N.
- Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies Front Biosci (Landmark Ed). 2023 Aug 17;28(8):171. Aktas T, Kizmazoglu D, Aktas S, Erol A, Serinan E, Gokbayrak O, Ozdemir SM, Altun Z, Ozer E, Cecen E, Ince D, Olgun N.
- Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience. Front Oncol. 2022 Dec 23;12:1041443 Olgun N, Cecen E, Ince D, Kizmazoglu D, Baysal B, Onal A, Ozdogan O, Guleryuz H, Cetingoz R, Demiral A, Olguner M, Celik A, Kamer S, Ozer E, Altun Z,
- Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group. J Cancer Res Ther. 2017 Apr-Jun;13(2):284-290. Aksoylar S, Varan A, Vergin C, Hazar V, Akici F, Dagdemir A, Buyukavci M, Kebudi R, Kurucu N, Sevinir B, Unal E, Vural S, Guler E, Apak H, Oniz H, Kar
- Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol. Pediatr Hematol Oncol. 2003 Apr-May;20(3):211-8. Olgun N, Kansoy S, Aksoylar S, Cetingul N, Vergin C, Oniz H, Sarialioglu F, Kantar M, Uysal K, Tuncyurek M, Kargi A, Aktas S, Bayol U, Karaca I, Arika
Frequently Asked Questions
What is Dr. Nur Olgun's specialty?
Which hospital does Dr. Nur Olgun practise at?
What languages can I use when consulting Dr. Nur Olgun?
How can I book an appointment with Dr. Nur Olgun?
Is an online video consultation available with Dr. Nur Olgun?
How many years of experience does Dr. Nur Olgun have?
Can international patients arrange treatment with Dr. Nur Olgun?
How do I get a second opinion involving Dr. Nur Olgun?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Prof. Dr. Nur Olgun
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Hospitals
What patients say about Prof. Dr. Nur Olgun
★★★★★From 2,400+ verified patient reviews“My anaesthesia care exceeded every expectation I had. Dr. Olguner explained every step clearly and never rushed me. I am deeply grateful for everything.”
“We brought our child in for cancer treatment and the care was wonderful. Prof. Dr. Olgun answered all our worried questions without making us feel silly. The facilities were spotless and modern.”